Lucio Iannone is a seasoned healthcare investor with over 15 years of experience across venture capital, board management, and biotechnology. Before joining the T1D Fund, Lucio served as the Head of Health Investments at Leaps by Bayer, where he spearheaded the global investment team, driving strategy and deal execution. In this role, Lucio directed assets under management totaling over $1 billion as he led the global investment team and strategic dealmaking processes. With a keen eye for innovation, he actively engages in the sourcing, screening, and mentoring of pioneering companies that are at the forefront of transformative scientific advancements.

Lucio has served on the boards of innovative organizations like Mozart Therapeutics, eGenesis Biosciences, Souffle Therapeutics, and Immunitas Therapeutics. His extensive biotechnology background encompasses expertise in molecular biology, cell and gene therapy, with applications in oncology, autoimmune diseases, and cardiovascular health. He also has a deep history building and mentoring high-performing teams that drive innovation in these therapeutic areas.

Lucio earned his Ph.D. in Medicine from Imperial College London, where he developed his foundational expertise in medical science and translational research. He is passionate about solidifying his foundation in the medical sciences, advancing novel therapeutics, and enhancing his ability to identify and nurture the next generation of healthcare innovations.

Dan McNamara is an accomplished life sciences executive with over 15 years of experience spanning corporate strategy, business development, and enterprise operations across the healthcare ecosystem. Prior to joining the T1D Fund, he served as Vice President of Enterprise Governance and Strategy & Business Development Operations at Bristol Myers Squibb (BMS), where he led strategic and operations functions in support of more than $100B in M&A and business development activity. In this role, he oversaw large-scale organization transformation efforts to shape corporate strategy, align capital deployment to long-term strategy, enhance cross-functional execution, and accelerate decision-making and the progression of the internally and externally sourced portfolio.

Before joining BMS, Dan founded SmarterAdmin, a healthcare-focused management consulting firm that served over 3,000 healthcare professionals across 100+ academic medical centers and institutions. He previously held senior roles at Columbia University Medical Center, where he led initiatives in financial planning and capital allocation, resource operations, and enterprise systems strategy.

Dan holds dual degrees in Finance and Psychology from the Robert H. Smith School of Business at the University of Maryland. He is passionate about applying strategic insight, cross-sector collaboration, and mission-driven innovation to accelerate progress in diseases with high unmet need, including Type 1 Diabetes.